Biomedical technology

Scientists first in the world to regenerate diseased kidney cells

In a world first, scientists at Duke-NUS Medical School, the National Heart Center Singapore (NHCS) and colleagues in Germany have shown that regenerative therapy to restore impaired kidney function may soon be a possibility.

Diabetes

HbA1c below 7.6% cuts long-term vascular complications in T1DM

(HealthDay)—For patients with type 1 diabetes, long-term weighted mean hemoglobin A1c (HbA1c) is associated with development of severe microvascular complications, according to a study published online Dec. 15 in Diabetes ...

Diseases, Conditions, Syndromes

Concern over intensive treatment for patients with type 2 diabetes

Doctors should be cautious about prescribing intensive glucose lowering treatment for patients with type 2 diabetes as a way of reducing heart complications, concludes a new study published in the British Medical Journal ...

Diabetes

Meeting dual HbA1c and LDL-C goals improves diabetes care

(HealthDay)—Dual achievement of both glycated hemoglobin (HbA1c) and low-density lipoprotein cholesterol (LDL-C) goals among patients with diabetes is associated with greater clinical and economic benefit than achievement ...

Diabetes

Report updates impact of hypoglycemia in diabetes

(HealthDay)—An update of the current state of knowledge about the impact of hypoglycemia on patients with diabetes reviews outcomes, strategies to prevent hypoglycemia, and current knowledge gaps, and has been published ...

Diabetes

No MI rate advantage for aggressive T2DM glucose control

(HealthDay)—In patients with type 2 diabetes, more aggressive glucose-control strategies have variable short-term effects on microvascular complications, but they do not reduce the rate of myocardial infarction over four ...

page 1 from 3